RESULTS	Comparison of the AIMS score in TD patients with various Val9Ala genotypes showed that the difference of AIMS scores in patients with TT and CT genotype was not significant ( P > 0.05 ) , but CTD did show a better efficacy in TD patients with CT heterozygote than in those with TT homozygote ( P < 0.05 ) .\